Citadel Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
Other funds holding IHI
Citadel Advisors's IHI Position: Q1 2026 in Review
Citadel Advisors sold out of iShares US Medical Devices ETF (IHI) in Q1 2026, closing a stake of 49,552 shares — an estimated $2.91M sold.
Citadel Advisors first reported a position in IHI in Q4 2014 and held it in 31 quarters. The position peaked at $12.1M in Q1 2024. 504 funds tracked by Wall St. Rank hold IHI as of Q1 2026.
- Citadel Advisors reported no remaining iShares US Medical Devices ETF position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 49,552 iShares US Medical Devices ETF shares in Q1 2026, an estimated $2.91M.
- Citadel Advisors first reported a position in iShares US Medical Devices ETF in Q4 2014 and held it in 31 quarters.
- Citadel Advisors's iShares US Medical Devices ETF position peaked at $12.1M in Q1 2024.
- 504 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.